KIR/HLA Gene Profile Implication in Systemic Sclerosis Patients from Mexico

Table 1

Demographic and clinical characteristics of SSc patients and CS.

	SSc; (%) ()	CS; (%) ()
Age (years)	48.7 (18-75)	48.3 (20-73)	0.9
Gender
Female	88 (44)	94.4 (85)	0.2
Male	12 (6)	5.5 (5)	0.2
Disease subtype
lcSSc	86 (43)	—
dcSSc	14 (7)	—
Disease duration (months)	94.8 (3-420)	—
Clinical manifestations
Sclerodactyly	88 (44)	—
Musculoskeletal damage	82 (41)	—
Raynaud’s phenomenon	70 (35)	—
Puffy fingers	68 (34)	—
Telangiectasia	54 (27)	—
Digital ulcers	40 (20)
Clinical evaluation
HAQ	0.4 (0-1.29)	—
MRSS51	7.3 (0-30)	—

Data are shown in median and rank in parentheses. SSc: Systemic Sclerosis; CS: Control Subjects; HAQ: Health Assessment Questionnaire disability index; MRSS51: Modified Rodnan Skin Score. Mann–Whitney U test; Fisher’s test.